Acute kidney injury (AKI) is a complex clinical condition associated with significant morbidity
and mortality and lacking effective management. Ischemia‑reperfusion injury (IRI) remains …

Acute kidney injury (AKI) represents a group of complicated syndromes with a high mortality
rate. The administration of adipose‐derived mesenchymal stem cells (ADMSC s) has been …

Introduction This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic
adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of …

Stem cells therapy has been suggested as a promising option for the treatment of acute
kidney injury (AKI). This study was performed to compare the abilities of xenogenic …

Background Reactive oxygen species are important mediators exerting toxic effects on
various organs during ischemia-reperfusion (IR) injury. We hypothesized that adipose …

It has been shown that administration of adipose derived mesenchymal stem cells
(AdMSCs) enhanced structural and functional recovery of renal ischemia‐reperfusion (IR) …

Background Acute kidney injury (AKI) is a critical condition for kidney and other remote
organs, including the lung. However, available treatments for AKI are limited. In this study …

Acute kidney injury (AKI) is a rapid loss of renal function. It has high mortality rates. Still,
renal replacement therapy is considered the best solution for recovering AKI. This opens a …

Background In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat …

Adipose-derived mesenchymal stem cells have been used to treat acute kidney injury (AKI).
The role of endoplasmic reticulum (ER) stress in AKI treatment with canine adipose-derived …